Computing the Weil representation of a superelliptic curve

We study the Weil representation $\rho$ of a curve over a $p$-adic field with potential reduction of compact type. We show that $\rho$ can be reconstructed from its stable reduction. For superelliptic curves of the form $y^n=f(x)$ at primes $p$ whose residue characteristic is prime to the exponent $n$ we make this explicit

A STUDY ON MULTI-OBJECTIVE OPTIMIZATION OF PLUNGE CENTERLESS GRINDING PROCESS

ABSTRACT Round component with the minimum value of surface roughness and roundness error is the goal of most of the fine machine processes. This paper presents the research on optimization of plunge centerless grinding process when grinding the 20X-carbon infiltration steel (ГOCT standardRussia) to achieve the minimum value of surface roughness and roundness errors. The input parameters are center height angle of the workpiece ( β ), longitudinal dressing feed-rate ( sd S ), plunge feed-rate ( k S ) and control wheel velocity ( dd v ) using the result of 29 sets in central composite design matrix to show the two second orders of surface rounghness and roundness error models. The final goal of this work focuses on the determination of optimum centerless grinding above the parameters for the minimization of surface roughness ( m R

Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021

Background: Estimates of demographic metrics are crucial to assess levels and trends of population health outcomes. The profound impact of the COVID-19 pandemic on populations worldwide has underscored the need for timely estimates to understand this unprecedented event within the context of long-term population health trends. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021 provides new demographic estimates for 204 countries and territories and 811 additional subnational locations from 1950 to 2021, with a particular emphasis on changes in mortality and life expectancy that occurred during the 2020–21 COVID-19 pandemic period. Methods: 22 223 data sources from vital registration, sample registration, surveys, censuses, and other sources were used to estimate mortality, with a subset of these sources used exclusively to estimate excess mortality due to the COVID-19 pandemic. 2026 data sources were used for population estimation. Additional sources were used to estimate migration; the effects of the HIV epidemic; and demographic discontinuities due to conflicts, famines, natural disasters, and pandemics, which are used as inputs for estimating mortality and population. Spatiotemporal Gaussian process regression (ST-GPR) was used to generate under-5 mortality rates, which synthesised 30 763 location-years of vital registration and sample registration data, 1365 surveys and censuses, and 80 other sources. ST-GPR was also used to estimate adult mortality (between ages 15 and 59 years) based on information from 31 642 location-years of vital registration and sample registration data, 355 surveys and censuses, and 24 other sources. Estimates of child and adult mortality rates were then used to generate life tables with a relational model life table system. For countries with large HIV epidemics, life tables were adjusted using independent estimates of HIV-specific mortality generated via an epidemiological analysis of HIV prevalence surveys, antenatal clinic serosurveillance, and other data sources. Excess mortality due to the COVID-19 pandemic in 2020 and 2021 was determined by subtracting observed all-cause mortality (adjusted for late registration and mortality anomalies) from the mortality expected in the absence of the pandemic. Expected mortality was calculated based on historical trends using an ensemble of models. In location-years where all-cause mortality data were unavailable, we estimated excess mortality rates using a regression model with covariates pertaining to the pandemic. Population size was computed using a Bayesian hierarchical cohort component model. Life expectancy was calculated using age-specific mortality rates and standard demographic methods. Uncertainty intervals (UIs) were calculated for every metric using the 25th and 975th ordered values from a 1000-draw posterior distribution. Findings: Global all-cause mortality followed two distinct patterns over the study period: age-standardised mortality rates declined between 1950 and 2019 (a 62·8% [95% UI 60·5–65·1] decline), and increased during the COVID-19 pandemic period (2020–21; 5·1% [0·9–9·6] increase). In contrast with the overall reverse in mortality trends during the pandemic period, child mortality continued to decline, with 4·66 million (3·98–5·50) global deaths in children younger than 5 years in 2021 compared with 5·21 million (4·50–6·01) in 2019. An estimated 131 million (126–137) people died globally from all causes in 2020 and 2021 combined, of which 15·9 million (14·7–17·2) were due to the COVID-19 pandemic (measured by excess mortality, which includes deaths directly due to SARS-CoV-2 infection and those indirectly due to other social, economic, or behavioural changes associated with the pandemic). Excess mortality rates exceeded 150 deaths per 100 000 population during at least one year of the pandemic in 80 countries and territories, whereas 20 nations had a negative excess mortality rate in 2020 or 2021, indicating that all-cause mortality in these countries was lower during the pandemic than expected based on historical trends. Between 1950 and 2021, global life expectancy at birth increased by 22·7 years (20·8–24·8), from 49·0 years (46·7–51·3) to 71·7 years (70·9–72·5). Global life expectancy at birth declined by 1·6 years (1·0–2·2) between 2019 and 2021, reversing historical trends. An increase in life expectancy was only observed in 32 (15·7%) of 204 countries and territories between 2019 and 2021. The global population reached 7·89 billion (7·67–8·13) people in 2021, by which time 56 of 204 countries and territories had peaked and subsequently populations have declined. The largest proportion of population growth between 2020 and 2021 was in sub-Saharan Africa (39·5% [28·4–52·7]) and south Asia (26·3% [9·0–44·7]). From 2000 to 2021, the ratio of the population aged 65 years and older to the population aged younger than 15 years increased in 188 (92·2%) of 204 nations. Interpretation: Global adult mortality rates markedly increased during the COVID-19 pandemic in 2020 and 2021, reversing past decreasing trends, while child mortality rates continued to decline, albeit more slowly than in earlier years. Although COVID-19 had a substantial impact on many demographic indicators during the first 2 years of the pandemic, overall global health progress over the 72 years evaluated has been profound, with considerable improvements in mortality and life expectancy. Additionally, we observed a deceleration of global population growth since 2017, despite steady or increasing growth in lower-income countries, combined with a continued global shift of population age structures towards older ages. These demographic changes will likely present future challenges to health systems, economies, and societies. The comprehensive demographic estimates reported here will enable researchers, policy makers, health practitioners, and other key stakeholders to better understand and address the profound changes that have occurred in the global health landscape following the first 2 years of the COVID-19 pandemic, and longer-term trends beyond the pandemic

Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021

BACKGROUND: Estimates of demographic metrics are crucial to assess levels and trends of population health outcomes. The profound impact of the COVID-19 pandemic on populations worldwide has underscored the need for timely estimates to understand this unprecedented event within the context of long-term population health trends. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021 provides new demographic estimates for 204 countries and territories and 811 additional subnational locations from 1950 to 2021, with a particular emphasis on changes in mortality and life expectancy that occurred during the 2020–21 COVID-19 pandemic period. METHODS: 22 223 data sources from vital registration, sample registration, surveys, censuses, and other sources were used to estimate mortality, with a subset of these sources used exclusively to estimate excess mortality due to the COVID-19 pandemic. 2026 data sources were used for population estimation. Additional sources were used to estimate migration; the effects of the HIV epidemic; and demographic discontinuities due to conflicts, famines, natural disasters, and pandemics, which are used as inputs for estimating mortality and population. Spatiotemporal Gaussian process regression (ST-GPR) was used to generate under-5 mortality rates, which synthesised 30 763 location-years of vital registration and sample registration data, 1365 surveys and censuses, and 80 other sources. ST-GPR was also used to estimate adult mortality (between ages 15 and 59 years) based on information from 31 642 location-years of vital registration and sample registration data, 355 surveys and censuses, and 24 other sources. Estimates of child and adult mortality rates were then used to generate life tables with a relational model life table system. For countries with large HIV epidemics, life tables were adjusted using independent estimates of HIV-specific mortality generated via an epidemiological analysis of HIV prevalence surveys, antenatal clinic serosurveillance, and other data sources. Excess mortality due to the COVID-19 pandemic in 2020 and 2021 was determined by subtracting observed all-cause mortality (adjusted for late registration and mortality anomalies) from the mortality expected in the absence of the pandemic. Expected mortality was calculated based on historical trends using an ensemble of models. In location-years where all-cause mortality data were unavailable, we estimated excess mortality rates using a regression model with covariates pertaining to the pandemic. Population size was computed using a Bayesian hierarchical cohort component model. Life expectancy was calculated using age-specific mortality rates and standard demographic methods. Uncertainty intervals (UIs) were calculated for every metric using the 25th and 975th ordered values from a 1000-draw posterior distribution. FINDINGS: Global all-cause mortality followed two distinct patterns over the study period: age-standardised mortality rates declined between 1950 and 2019 (a 62·8% [95% UI 60·5–65·1] decline), and increased during the COVID-19 pandemic period (2020–21; 5·1% [0·9–9·6] increase). In contrast with the overall reverse in mortality trends during the pandemic period, child mortality continued to decline, with 4·66 million (3·98–5·50) global deaths in children younger than 5 years in 2021 compared with 5·21 million (4·50–6·01) in 2019. An estimated 131 million (126–137) people died globally from all causes in 2020 and 2021 combined, of which 15·9 million (14·7–17·2) were due to the COVID-19 pandemic (measured by excess mortality, which includes deaths directly due to SARS-CoV-2 infection and those indirectly due to other social, economic, or behavioural changes associated with the pandemic). Excess mortality rates exceeded 150 deaths per 100 000 population during at least one year of the pandemic in 80 countries and territories, whereas 20 nations had a negative excess mortality rate in 2020 or 2021, indicating that all-cause mortality in these countries was lower during the pandemic than expected based on historical trends. Between 1950 and 2021, global life expectancy at birth increased by 22·7 years (20·8–24·8), from 49·0 years (46·7–51·3) to 71·7 years (70·9–72·5). Global life expectancy at birth declined by 1·6 years (1·0–2·2) between 2019 and 2021, reversing historical trends. An increase in life expectancy was only observed in 32 (15·7%) of 204 countries and territories between 2019 and 2021. The global population reached 7·89 billion (7·67–8·13) people in 2021, by which time 56 of 204 countries and territories had peaked and subsequently populations have declined. The largest proportion of population growth between 2020 and 2021 was in sub-Saharan Africa (39·5% [28·4–52·7]) and south Asia (26·3% [9·0–44·7]). From 2000 to 2021, the ratio of the population aged 65 years and older to the population aged younger than 15 years increased in 188 (92·2%) of 204 nations. INTERPRETATION: Global adult mortality rates markedly increased during the COVID-19 pandemic in 2020 and 2021, reversing past decreasing trends, while child mortality rates continued to decline, albeit more slowly than in earlier years. Although COVID-19 had a substantial impact on many demographic indicators during the first 2 years of the pandemic, overall global health progress over the 72 years evaluated has been profound, with considerable improvements in mortality and life expectancy. Additionally, we observed a deceleration of global population growth since 2017, despite steady or increasing growth in lower-income countries, combined with a continued global shift of population age structures towards older ages. These demographic changes will likely present future challenges to health systems, economies, and societies. The comprehensive demographic estimates reported here will enable researchers, policy makers, health practitioners, and other key stakeholders to better understand and address the profound changes that have occurred in the global health landscape following the first 2 years of the COVID-19 pandemic, and longer-term trends beyond the pandemic. FUNDING: Bill & Melinda Gates Foundation

Global medicine :a case study of transnational intervention.

This project strove to understand and help The Child Medical Connection (CMC), a non-profit organization founded and directed by Mr. Joseph Bodanza in Leominster, Massachusetts. The CMC brings handicapped children from Vietnam for treatment at the Shriner's Hospital in Springfield, MA. The project team translated documents and conversations for the CMC, accompanied patients to and from the hospital, and investigated alternative technologies and organizations that might carry on the CMC's work, and finally publicized the CMC in the Vietnamese community of Worcester, MA

A new species of Hemiphyllodactylus Bleeker, 1860 (Squamata: Gekkonidae) from Da Lat Plateau, Vietnam

We describe a new species of the genus Hemiphyllodactylus on the basis of four specimens from Bidoup -Nui Ba National Park, Da Lat Plateau, Lam Dong Province, Vietnam. The new species, Hemiphyllodactylus dalatensis sp. nov., is distinguished from the remaining congeners by a combination of the following characters: a bisexual taxon; maximum SVL of 45.9 mm; dorsal scale rows 16; ventral scale rows 8 or 9; chin scales 7-10; postmental scales enlarged; femoral and precloacal pores in a continuous series, 23-25 in total in males, absent in the female; digital lamellae formula 4-55/6-5 (forefoot) and 5-6-6-6/5 (hind foot); cloacal spurs 2 or 3 on each side in both males and female; subcaudal scales not enlarged; dorsal trunk pattern with two paravertebral stripes, formed by two rows of dark spots; dark lateral head stripe distinct; postsacral mark cream or orange and bearing anteriorly projecting arms. In phylogenetic analyses, the new species is recovered as the sister taxon to a clade including all species from India although support values are low from all analyses

Acinic cell carcinoma of parotid gland

Acinic cell carcinoma (ACC) is a rare malignant tumor of the salivary glands that accounts for 6%-10% of all salivary gland malignancies. It has a propensity to considerably recur, metastasize to the lung or cervical lymph nodes. In addition, ACC can potentially be fatal. The parotid gland is where ACC most frequently begins. The purpose of this paper was to describe an unusual case of parotid gland ACC in a 58-year-old Vietnamese adult female. Before surgery, a fine-needle aspiration biopsy revealed the existence of tumor cells with acinar differentiation. Following that, she underwent successful surgery without complications. The existence of ACC was verified by the postoperative final histologic results

Assessing the Performance of Climate Smart Rice Production Systems in the Upper Part of the Vietnamese Mekong River Delta

Climate smart agriculture (CSA) has gained considerable attention in Vietnam due to its potential to increase food security and farming system resilience while decreasing greenhouse gas emissions. In recent years, several CSA practices have been introduced in rice production, the most important sub-sector of Vietnam’s agriculture. However, few studies have been done in Vietnam to produce comprehensive assessments of CSA performance in the rice sector. This research proposes a comprehensive approach to assess CSA practices through a new set of evaluation indicators. A case study in An Giang province of the Vietnamese Mekong River Delta was implemented to evaluate the performance of five CSA models versus that of the triple rice crop system (i.e., benchmarking model). Results show that rice-shrimp and rice-lotus rotations are most profitable, low-risk, and applicable at a larger scale. Given that the current study analyzed and calculated only a small number of indicators and types of CSA practices, further research is necessary to test all indicators and diversified types of CSA models

RGB-D to CAD retrieval with objectNN dataset

The goal of this track is to study and evaluate the performance of 3D object retrieval algorithms using RGB-D data. This is inspired from the practical need to pair an object acquired from a consumer-grade depth camera to CAD models available in public datasets on the Internet. To support the study, we propose ObjectNN, a new dataset with well segmented and annotated RGB-D objects from SceneNN [HPN*16] and CAD models from ShapeNet [CFG*15]. The evaluation results show that the RGB-D to CAD retrieval problem, while being challenging to solve due to partial and noisy 3D reconstruction, can be addressed to a good extent using deep learning techniques, particularly, convolutional neural networks trained by multi-view and 3D geometry. The best method in this track scores 82% in accuracy

SHREC\u2717: RgB-D to CAD Retrieval With ObjectNN Dataset

© 2017 The Eurographics Association. The goal of this track is to study and evaluate the performance of 3D object retrieval algorithms using RGB-D data. This is inspired from the practical need to pair an object acquired from a consumer-grade depth camera to CAD models available in public datasets on the Internet. To support the study, we propose ObjectNN, a new dataset with well segmented and annotated RGB-D objects from SceneNN [HPN∗16] and CAD models from ShapeNet [CFG∗15]. The evaluation results show that the RGB-D to CAD retrieval problem, while being challenging to solve due to partial and noisy 3D reconstruction, can be addressed to a good extent using deep learning techniques, particularly, convolutional neural networks trained by multi-view and 3D geometry. The best method in this track scores 82% in accuracy